Replies to post #18032 on Biotech Values

[DewDiligence]

>I expect the company's price to appreciate significantly over the next 3 mo. as I stated earlier. I believe there will be upgrades and supporting company news releases to follow.<

I concur with the second half of your remark.

Over the next year, I expect DNDN to flood the newswires with PR update on Neuvenge, Trp-p8, and various other topics. The question is: when will they issue the PR that longs are hoping for—the one that says they’ve completed (not just started) the BLA submission?